• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于配体的虚拟筛选方法,使用泛化能力的直接量化。

A Ligand-Based Virtual Screening Method Using Direct Quantification of Generalization Ability.

机构信息

School of Life Science and State Key Laboratory of Agrobiotechnology, G94, Science Center South Block, The Chinese University of Hong Kong, Shatin 999077, Hong Kong.

出版信息

Molecules. 2019 Jun 30;24(13):2414. doi: 10.3390/molecules24132414.

DOI:10.3390/molecules24132414
PMID:31262005
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6651094/
Abstract

Machine learning plays an important role in ligand-based virtual screening. However, conventional machine learning approaches tend to be inefficient when dealing with such problems where the data are imbalanced and features describing the chemical characteristic of ligands are high-dimensional. We here describe a machine learning algorithm LBS (local beta screening) for ligand-based virtual screening. The unique characteristic of LBS is that it quantifies the generalization ability of screening directly by a refined loss function, and thus can assess the risk of over-fitting accurately and efficiently for imbalanced and high-dimensional data in ligand-based virtual screening without the help of resampling methods such as cross validation. The robustness of LBS was demonstrated by a simulation study and tests on real datasets, in which LBS outperformed conventional algorithms in terms of screening accuracy and model interpretation. LBS was then used for screening potential activators of HIV-1 integrase multimerization in an independent compound library, and the virtual screening result was experimentally validated. Of the 25 compounds tested, six were proved to be active. The most potent compound in experimental validation showed an EC value of 0.71 µM.

摘要

机器学习在基于配体的虚拟筛选中起着重要作用。然而,传统的机器学习方法在处理数据不平衡且描述配体化学特征的特征高维的问题时往往效率低下。我们在这里描述了一种用于基于配体的虚拟筛选的机器学习算法 LBS(局部β筛选)。LBS 的独特特征在于,它通过细化的损失函数直接量化筛选的泛化能力,因此可以在没有交叉验证等重采样方法的帮助下,准确有效地评估基于配体的虚拟筛选中不平衡和高维数据的过拟合风险。通过模拟研究和对真实数据集的测试,证明了 LBS 的稳健性,在筛选准确性和模型解释方面,LBS 优于传统算法。然后,LBS 用于筛选 HIV-1 整合酶多聚化的潜在激活剂的独立化合物库,虚拟筛选结果经过实验验证。在测试的 25 种化合物中,有 6 种被证明是有效的。实验验证中最有效的化合物的 EC 值为 0.71µM。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5dd7/6651094/6ec85a409846/molecules-24-02414-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5dd7/6651094/1a8ab7a52c77/molecules-24-02414-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5dd7/6651094/b6d87bfe5319/molecules-24-02414-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5dd7/6651094/a56fe1884f6c/molecules-24-02414-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5dd7/6651094/e339d71d88e5/molecules-24-02414-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5dd7/6651094/0c656078ed68/molecules-24-02414-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5dd7/6651094/6ec85a409846/molecules-24-02414-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5dd7/6651094/1a8ab7a52c77/molecules-24-02414-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5dd7/6651094/b6d87bfe5319/molecules-24-02414-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5dd7/6651094/a56fe1884f6c/molecules-24-02414-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5dd7/6651094/e339d71d88e5/molecules-24-02414-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5dd7/6651094/0c656078ed68/molecules-24-02414-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5dd7/6651094/6ec85a409846/molecules-24-02414-g008.jpg

相似文献

1
A Ligand-Based Virtual Screening Method Using Direct Quantification of Generalization Ability.基于配体的虚拟筛选方法,使用泛化能力的直接量化。
Molecules. 2019 Jun 30;24(13):2414. doi: 10.3390/molecules24132414.
2
Discovery of a novel HIV-1 integrase inhibitor from natural compounds through structure based virtual screening and cell imaging.基于结构的虚拟筛选和细胞成像从天然化合物中发现新型 HIV-1 整合酶抑制剂。
FEBS Lett. 2014 Sep 17;588(18):3461-8. doi: 10.1016/j.febslet.2014.08.004. Epub 2014 Aug 13.
3
Discovery of HIV-1 integrase inhibitors: pharmacophore mapping, virtual screening, molecular docking, synthesis, and biological evaluation.HIV-1整合酶抑制剂的发现:药效团映射、虚拟筛选、分子对接、合成及生物学评价
Chem Biol Drug Des. 2014 Feb;83(2):154-66. doi: 10.1111/cbdd.12207. Epub 2013 Oct 4.
4
Study of Structure-active Relationship for Inhibitors of HIV-1 Integrase LEDGF/p75 Interaction by Machine Learning Methods.基于机器学习方法的HIV-1整合酶与LEDGF/p75相互作用抑制剂的构效关系研究
Mol Inform. 2017 Jul;36(7). doi: 10.1002/minf.201600127. Epub 2017 Feb 28.
5
Novel HIV-1 Integrase Inhibitor Development by Virtual Screening Based on QSAR Models.基于定量构效关系模型的虚拟筛选开发新型HIV-1整合酶抑制剂
Curr Top Med Chem. 2016;16(4):441-8. doi: 10.2174/1568026615666150813150433.
6
Discovery of HIV-1 integrase inhibitors through a novel combination of ligand and structure-based drug design.通过基于配体和结构的药物设计的新组合发现HIV-1整合酶抑制剂。
Med Chem. 2005 May;1(3):263-75. doi: 10.2174/1573406053765440.
7
Ligand-Based Virtual Screening in a Search for Novel Anti-HIV-1 Chemotypes.基于配体的虚拟筛选在寻找新型抗 HIV-1 化学型中的应用。
J Chem Inf Model. 2015 Oct 26;55(10):2168-77. doi: 10.1021/acs.jcim.5b00295. Epub 2015 Oct 9.
8
An effective HIV-1 integrase inhibitor screening platform: Rationality validation of drug screening, conformational mobility and molecular recognition analysis for PFV integrase complex with viral DNA.一种有效的HIV-1整合酶抑制剂筛选平台:药物筛选的合理性验证、PFV整合酶与病毒DNA复合物的构象流动性及分子识别分析
J Mol Graph Model. 2017 Nov;78:96-109. doi: 10.1016/j.jmgm.2017.10.002. Epub 2017 Oct 5.
9
Novel HIV integrase inhibitors with anti-HIV activity: insights into integrase inhibition from docking studies.具有抗HIV活性的新型HIV整合酶抑制剂:基于对接研究对整合酶抑制作用的深入了解
Antivir Chem Chemother. 2006;17(6):343-53. doi: 10.1177/095632020601700604.
10
Automated Inference of Chemical Discriminants of Biological Activity.生物活性化学判别因子的自动推断
Methods Mol Biol. 2018;1762:307-338. doi: 10.1007/978-1-4939-7756-7_16.

引用本文的文献

1
A comprehensive review of artificial intelligence for pharmacology research.药理学研究中人工智能的全面综述。
Front Genet. 2024 Sep 3;15:1450529. doi: 10.3389/fgene.2024.1450529. eCollection 2024.
2
Opportunities and challenges in application of artificial intelligence in pharmacology.人工智能在药理学应用中的机遇与挑战。
Pharmacol Rep. 2023 Feb;75(1):3-18. doi: 10.1007/s43440-022-00445-1. Epub 2023 Jan 9.
3
Identification of immucillin analogue natural compounds to inhibit MTAN through high throughput virtual screening and molecular dynamics simulation.

本文引用的文献

1
Machine Learning Distinguishes with High Accuracy between Pan-Assay Interference Compounds That Are Promiscuous or Represent Dark Chemical Matter.机器学习能够高精度地区分具有混杂性或代表暗物质的泛分析干扰化合物。
J Med Chem. 2018 Nov 21;61(22):10255-10264. doi: 10.1021/acs.jmedchem.8b01404. Epub 2018 Nov 13.
2
Profiling Prediction of Kinase Inhibitors: Toward the Virtual Assay.激酶抑制剂的特征预测:迈向虚拟分析
J Med Chem. 2017 Jan 12;60(1):474-485. doi: 10.1021/acs.jmedchem.6b01611. Epub 2016 Dec 14.
3
Deep learning.深度学习。
通过高通量虚拟筛选和分子动力学模拟鉴定抑制MTAN的亚胺环醇类似物天然化合物。
In Silico Pharmacol. 2021 Mar 11;9(1):22. doi: 10.1007/s40203-021-00081-2. eCollection 2021.
Nature. 2015 May 28;521(7553):436-44. doi: 10.1038/nature14539.
4
Multimode, cooperative mechanism of action of allosteric HIV-1 integrase inhibitors.变构 HIV-1 整合酶抑制剂的多模式协同作用机制。
J Biol Chem. 2012 May 11;287(20):16801-11. doi: 10.1074/jbc.M112.354373. Epub 2012 Mar 21.
5
A problem of dimensionality: a simple example.维度问题:一个简单的例子。
IEEE Trans Pattern Anal Mach Intell. 1979 Mar;1(3):306-7. doi: 10.1109/tpami.1979.4766926.
6
Molecular docking: a powerful approach for structure-based drug discovery.分子对接:基于结构的药物发现的强大方法。
Curr Comput Aided Drug Des. 2011 Jun;7(2):146-57. doi: 10.2174/157340911795677602.
7
Extended-connectivity fingerprints.扩展连接指纹。
J Chem Inf Model. 2010 May 24;50(5):742-54. doi: 10.1021/ci100050t.
8
Virtual screening: an endless staircase?虚拟筛选:没有尽头的阶梯?
Nat Rev Drug Discov. 2010 Apr;9(4):273-6. doi: 10.1038/nrd3139.
9
Virtual screening of bioassay data.生物测定数据的虚拟筛选。
J Cheminform. 2009 Dec 22;1:21. doi: 10.1186/1758-2946-1-21.
10
An allosteric mechanism for inhibiting HIV-1 integrase with a small molecule.一种用小分子抑制HIV-1整合酶的变构机制。
Mol Pharmacol. 2009 Oct;76(4):824-32. doi: 10.1124/mol.109.058883. Epub 2009 Jul 28.